The surge of medtech M&A deals in September failed to keep the momentum going in October, with a sharp drop in deal volume, dashing hopes of a Q4 turnaround. Medtech Insight 's M&A deal tracker recorded ten mergers and acquisitions that were announced and/or completed, marking October as one of the weakest months of the year so far.
Deal volume plummeted from the September boom, which recorded 23 deals, and was not even able to surpass August's modest...